Belite Bio(BLTE)
Search documents
Belite Bio(BLTE) - 2023 Q1 - Earnings Call Transcript
2023-05-14 08:42
Belite Bio, Inc (NASDAQ:BLTE) Q1 2023 Earnings Conference Call May 11, 2023 8:00 AM ET Operator Thank you, Tara. Thank you, everyone, for joining our financial results for first quarter 2023. Joining me today is our CSO, Nathan Mata, who will be updating our recent clinical trial progress; and our CFO, Hao-Yuan, who will be updating our Q1 financial results. And now I would like to pass it on to our CSO to give an update on our clinical trials. Nathan? In fact, we've had interim analyses that's periodically ...
Belite Bio(BLTE) - 2022 Q4 - Earnings Call Transcript
2023-04-04 00:39
Okay. So are the patients in the ongoing Phase 2 trial -- is the requirement the same for the patients in ongoing Phase 2 trial and the Phase 3 DRAGON trial? Nathan Mata I see. And what's the requirement for the dry AMD patients? Our next question comes from Bruce Jackson from Benchmark. Nathan Mata Our next question comes from Yuan Zhi from B. Riley. Nathan Mata Yes, so from 60 to 90 patients, and you mentioned that the interim analysis will have a better chance to reach statistical significance. Yuan Zhi ...
Belite Bio(BLTE) - 2022 Q4 - Annual Report
2023-03-30 16:00
17 The incidence and prevalence for target patient populations of our product candidates are based on estimates and third-party sources. The market opportunities for our product candidates, if approved, may be smaller than we anticipate. The illegal importation of competing products from countries where government price controls or other market dynamics result in lower prices may adversely affect the demand for our future approved product candidates and, in turn, may adversely affect our sales and profitabi ...
Belite Bio(BLTE) - 2022 Q2 - Earnings Call Transcript
2022-08-13 06:35
Belite Bio, Inc (NASDAQ:BLTE) Q2 2022 Earnings Conference Call August 11, 2022 4:30 PM ET Company Participants Tom Lin – Chief Executive Officer Nathan Mata – Chief Scientific Officer Hao-Yuan Chuang – Chief Financial Officer Conference Call Participants Bruce Jackson – The Benchmark Company Unidentified Company Representative [Call Starts Abruptly] First Half 2022 Financial Results Conference Call. After todayÂ's presentation, there will be an opportunity to ask questions. [Operator Instructions] Please no ...